Clinical Trial Update: Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

View source ↗

Summary

This clinical trial update reports on humoral and cellular immune responses to a SARS-CoV-2 vaccine in HIV-infected, immunosuppressed individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SARS-CoV-2 vaccine

Snippet

Sponsor: Hospitales Universitarios Virgen del Rocío | Conditions: SARS-CoV-2 RNA Vaccines, HIV Infection | Status: COMPLETED